https://www.pharmaceutical-technology.com/news/mesoblast-plans-new-gvhd-trial-after-another-fda-rejections/
Mesoblast plans follows an FDA response to the BLA resubmission for remestemcel-L for treating pediatric steroid-refractory acute GvHD.
plans newmesoblastgvhdtrialanother
https://www.pharmaceutical-technology.com/news/newsdeals-this-week-mesoblast-limited-orexigen-therapeutics-ireland-ltd-savior-lifetec-corporation-5774391/
Mesoblast has raised A$52.5m ($40m) from a fully underwritten private placement of shares to its existing global institutional investors, as well as new...
orexigen therapeuticsdealsweekmesoblastireland
https://www.fool.com.au/2025/12/30/why-droneshield-ipd-mesoblast-and-woodside-shares-are-charging-higher-today/
Dec 30, 2025 - DroneShield Ltd (ASX: DRO) and Mesoblast Ltd (ASX: MSB) are two of four ASX shares rising on Tuesday...
droneshieldipdmesoblastwoodsideshares
https://www.webull.com/quote/otcpk-meobf
Webull offers Mesoblast (MEOBF) historical stock prices, in-depth market analysis, OTCPK: MEOBF real-time stock quote data, in-depth charts.
stock quotesmesoblastwebull
https://www.technologynetworks.com/cell-science/news/mesoblast-reports-halfyear-2013-financial-results-200716
Provides strategic update on key areas of product development.
financial resultsmesoblastreportshalfyear